Tianjin Chase Sun Pharmaceutical Co Ltd (300026) — Cash Flow Quality Index
Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a Cash Flow Quality Index of 71.88x as of September 2025. Operating cash flow of CN¥153.30 Million exceeds net income of CN¥2.13 Million, indicating high earnings quality where cash backs reported profits. Explore Tianjin Chase Sun Pharmaceutical Co Ltd (300026) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Tianjin Chase Sun Pharmaceutical Co Ltd Cash Flow Quality Index (2006–2024)
Historical Cash Flow Quality Index for Tianjin Chase Sun Pharmaceutical Co Ltd across 19 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Tianjin Chase Sun Pharmaceutical Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)
Year-by-year earnings quality comparison for Tianjin Chase Sun Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see 300026 market cap.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 37.14x | CN¥852.24 Million | CN¥22.95 Million | ▲ +1117.5% |
| 2023 | 3.05x | CN¥1.53 Billion | CN¥501.57 Million | ▲ +154.2% |
| 2022 | 1.20x | CN¥745.35 Million | CN¥620.97 Million | ▲ +105.6% |
| 2021 | 0.58x | CN¥391.60 Million | CN¥670.85 Million | ▲ +66.1% |
| 2020 | 0.35x | CN¥196.66 Million | CN¥559.68 Million | ▼ -33.6% |
| 2019 | 0.53x | CN¥216.10 Million | CN¥408.43 Million | ▼ -70.6% |
| 2018 | 1.80x | CN¥388.19 Million | CN¥215.91 Million | ▲ +8.3% |
| 2017 | 1.66x | CN¥742.38 Million | CN¥447.21 Million | ▲ +144.9% |
| 2016 | 0.68x | CN¥448.08 Million | CN¥661.08 Million | ▲ +200.4% |
| 2015 | 0.23x | CN¥121.00 Million | CN¥536.23 Million | ▼ -32.4% |
| 2014 | 0.33x | CN¥149.94 Million | CN¥448.94 Million | ▼ -20.7% |
| 2013 | 0.42x | CN¥143.60 Million | CN¥340.90 Million | ▼ -27.9% |
| 2012 | 0.58x | CN¥152.21 Million | CN¥260.68 Million | ▲ +147.2% |
| 2011 | 0.24x | CN¥35.64 Million | CN¥150.91 Million | ▼ -42.1% |
| 2010 | 0.41x | CN¥46.25 Million | CN¥113.35 Million | ▼ -75.5% |
| 2009 | 1.67x | CN¥135.06 Million | CN¥80.97 Million | ▲ +38.2% |
| 2008 | 1.21x | CN¥77.74 Million | CN¥64.39 Million | ▼ -34.4% |
| 2007 | 1.84x | CN¥72.01 Million | CN¥39.16 Million | ▲ +1005.9% |
| 2006 | 0.17x | CN¥1.22 Million | CN¥7.36 Million | — |